MONITORING CELLULAR IMMUNE RESPONSES TO CMV TO GUIDE THERAPY OF CMV DISEASE IN PEDIATRIC RENAL TRANSPLANT (Tx) RECIPIENTS

被引：0
|
作者：
Puliyanda, Dechu P. [1 ]
Ge, Shili [1 ]
Karasyov, Artur [1 ]
Jordan, Stanley C. [1 ]
Kamil, Elaine S. [1 ]
Toyoda, Mieko [1 ]
机构：
[1] Cedars Sinai Med Ctr, Pediat Nephrol & Transplant Immunol Lab, Los Angeles, CA 90048 USA
来源：
PEDIATRIC TRANSPLANTATION | 2011年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
257
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [21] Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients
    Ljungman, Per
    JOURNAL OF CLINICAL VIROLOGY, 2006, 35 (04) : 493 - 495
  • [22] Incidence of CMV with dual therapy prophylaxis in renal transplant recipients.
    Baillie, GM
    Ashcraft, EE
    Polito, CC
    Buchanan, EP
    Rodwell, D
    Emovon, O
    Afzal, F
    Rogers, J
    Lin, A
    Brown, E
    Baliga, PK
    Rajagopalan, PR
    Chavin, KD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 780A - 780A
  • [23] Diagnosis of active CMV infection in renal transplant recipients by CMV antigenaemia.
    Noveljic, Z
    Walele, AA
    van Rensburg, EJ
    Moosa, MR
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 2126 - 2126
  • [24] CMV Viremia and Development of CMV-Specific Cytotoxic T-Cells (CMV-Tc) in Pediatric Renal Transplant Recipients.
    Pizzo, H.
    Shin, B.
    Toyoda, M.
    Jordan, S.
    Puliyanda, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 946 - 946
  • [25] CYTOMEGALOVIRUS (CMV) INFECTIONS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS - ROLE OF GANCYCLOVIR
    DABBAGH, S
    MCWILLIAMS, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1079 - 1079
  • [26] Long-term CMV monitoring and chronic rejection in renal transplant recipients
    Ishikawa, Shoko
    Tasaki, Masayuki
    Saito, Kazuhide
    Nakagawa, Yuki
    Ikeda, Masahiro
    Takahashi, Kota
    Tomita, Yoshihiko
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [27] PREVENTION OF CYTOMEGALOVIRUS (CMV) DISEASE (DIS) BY PASSIVE-IMMUNIZATION IN A PEDIATRIC RENAL-TRANSPLANT (TX) POPULATION
    FLYNN, J
    SCHULMAN, S
    KAISER, B
    DUNN, S
    DEFOREST, A
    MOCHON, M
    BALUARTE, HJ
    CLINICAL RESEARCH, 1992, 40 (02): : A388 - A388
  • [28] Valganciclovir as CMV prophylaxis in pediatric transplant recipients.
    Bonatti, H
    Wiesmayr, S
    Junngraithmayr, TC
    Margreiter, R
    Zimmerhackl, LB
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 98 - 98
  • [29] Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease
    Woo, PCY
    Lo, CY
    Lo, SKF
    Siau, H
    Peiris, JSM
    Wong, SSY
    Luk, WK
    Chan, TM
    Lim, WW
    Yuen, KY
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (05) : 515 - 518
  • [30] IGM IMMUNE-COMPLEXES, LYMPHOCYTOTOXINS, AND RHEUMATOID FACTORS IN RENAL-TRANSPLANT RECIPIENTS WITH CMV DISEASE
    BALDWIN, WM
    CLAAS, FHJ
    VANGEMERT, GW
    WESTEDT, ML
    VANES, A
    DAHA, MR
    PAUL, LC
    VANES, LA
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1985, : 9 - 13
12345